AU2020423706B2 - High-purity mesenchymal stem cells - Google Patents

High-purity mesenchymal stem cells Download PDF

Info

Publication number
AU2020423706B2
AU2020423706B2 AU2020423706A AU2020423706A AU2020423706B2 AU 2020423706 B2 AU2020423706 B2 AU 2020423706B2 AU 2020423706 A AU2020423706 A AU 2020423706A AU 2020423706 A AU2020423706 A AU 2020423706A AU 2020423706 B2 AU2020423706 B2 AU 2020423706B2
Authority
AU
Australia
Prior art keywords
cell
cell population
less
lngfr
mesenchymal stem
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2020423706A
Other languages
English (en)
Other versions
AU2020423706A1 (en
Inventor
Yumi Matsuzaki
Takashi Suyama
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Purec Co Ltd
Original Assignee
Purec Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Purec Co Ltd filed Critical Purec Co Ltd
Publication of AU2020423706A1 publication Critical patent/AU2020423706A1/en
Application granted granted Critical
Publication of AU2020423706B2 publication Critical patent/AU2020423706B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0652Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662Stem cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0652Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662Stem cells
    • C12N5/0663Bone marrow mesenchymal stem cells (BM-MSC)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2330/00Production
    • C12N2330/10Production naturally occurring
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/02Atmosphere, e.g. low oxygen conditions
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10Growth factors
    • C12N2501/115Basic fibroblast growth factor (bFGF, FGF-2)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Rheumatology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU2020423706A 2020-01-16 2020-04-06 High-purity mesenchymal stem cells Active AU2020423706B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PCT/JP2020/002197 WO2021144995A1 (ja) 2020-01-16 2020-01-16 高純度間葉系幹細胞
AUPCT/JP2020/002197 2020-01-16
PCT/JP2020/016228 WO2021145002A1 (ja) 2020-01-16 2020-04-06 高純度間葉系幹細胞

Publications (2)

Publication Number Publication Date
AU2020423706A1 AU2020423706A1 (en) 2022-06-23
AU2020423706B2 true AU2020423706B2 (en) 2024-10-24

Family

ID=76864087

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2020423706A Active AU2020423706B2 (en) 2020-01-16 2020-04-06 High-purity mesenchymal stem cells

Country Status (9)

Country Link
US (1) US20230002735A1 (https=)
EP (1) EP4053266A4 (https=)
JP (2) JP7466218B2 (https=)
KR (1) KR20220084078A (https=)
CN (1) CN114846134B (https=)
AU (1) AU2020423706B2 (https=)
CA (1) CA3163517C (https=)
IL (1) IL293724A (https=)
WO (2) WO2021144995A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022177032A1 (ja) * 2021-02-19 2022-08-25 PuREC株式会社 骨疾患治療用医薬組成物
AU2024354962A1 (en) 2023-10-02 2026-03-12 National University Corporation Tokai National Higher Education And Research System Method for managing quality of stem cells by image analysis using ai
TW202529782A (zh) * 2023-10-05 2025-08-01 日商PuREC股份有限公司 含有高純度間葉系幹細胞之用以治療以及/或是預防粒線體疾病之組成物

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110053183A1 (en) * 2007-09-06 2011-03-03 Yumi Matsuzaki Method of concentrating human mesenchymal stem cells
AU2015297347B2 (en) * 2014-08-01 2021-05-27 PuREC Co., Ltd Method for evaluating quality of human mesenchymal stem cell, and monoclonal antibody for use in said method

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6025329B2 (ja) 1980-07-25 1985-06-18 株式会社日立製作所 鋼管移送騒音防止装置
DE102006043625B4 (de) * 2006-09-12 2012-02-23 Eberhard-Karls-Universität Tübingen Universitätsklinikum Verfahren zur Isolierung und/oder Identifizierung von mesenchymalen Stammzellen (MSC)
EP3124601A1 (en) * 2008-08-14 2017-02-01 Mesoblast International Sàrl Purified mesenchymal stem cell compositions and methods of purifying mesenchymal stem cell compositions
JP6463029B2 (ja) 2013-08-02 2019-01-30 有未 伊谷 ヒト間葉系幹細胞を特異的に認識するモノクローナル抗体並びにこれを用いたヒト間葉系幹細胞の分離及び/または品質評価を行う方法
KR20160017795A (ko) 2014-08-05 2016-02-17 삼성디스플레이 주식회사 박막 트랜지스터 기판, 이의 제조 방법, 및 박막 트랜지스터 기판을 포함하는 표시 장치
EP3336177A1 (fr) * 2016-12-16 2018-06-20 Stem Cell Vet Therapeutics Procede de culture, d'isolement et d'enrichissement de cellules souches mesenchymateuses clonogeniques, a fort rendement, en vue d'une utilisation therapeutique

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110053183A1 (en) * 2007-09-06 2011-03-03 Yumi Matsuzaki Method of concentrating human mesenchymal stem cells
AU2015297347B2 (en) * 2014-08-01 2021-05-27 PuREC Co., Ltd Method for evaluating quality of human mesenchymal stem cell, and monoclonal antibody for use in said method

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
MABUCHI Y. ET AL.: "LNGFR+THY-I+VCAM-Ihi+ cells reveal functionally distinct subpopulations in mesenchymal stem cells", STEM CELL REPORTS, vol. 1, 6 August 2013 (2013-08-06), pages 152 - 165, XP055391281, DOI: 10.1016/j.stemcr.2013.06.001 *
RESEARCH & DEVELOPMENT:2017.Research Seeds and Products Based on Those Seeds/Overview of Services. Development of Identification and Separation Method of High-quality MSC in Human Bone Marrow and(2)Research Results Obtained to Date. *

Also Published As

Publication number Publication date
CN114846134A (zh) 2022-08-02
WO2021145002A8 (ja) 2022-06-30
WO2021145002A1 (ja) 2021-07-22
JPWO2021145002A1 (https=) 2021-07-22
CN114846134B (zh) 2024-10-29
JP7466218B2 (ja) 2024-04-12
CA3163517A1 (en) 2021-07-22
AU2020423706A1 (en) 2022-06-23
IL293724A (en) 2022-08-01
US20230002735A1 (en) 2023-01-05
JP2024089675A (ja) 2024-07-03
WO2021144995A1 (ja) 2021-07-22
EP4053266A1 (en) 2022-09-07
CA3163517C (en) 2025-05-13
EP4053266A4 (en) 2023-01-11
JP7792151B2 (ja) 2025-12-25
KR20220084078A (ko) 2022-06-21

Similar Documents

Publication Publication Date Title
JP7792151B2 (ja) 高純度間葉系幹細胞
CA2954245C (en) Method for evaluating quality of human mesenchymal stem cell, and monoclonal antibody for use in said method
Kromenaker et al. Stability of producer hybridoma cell lines after cell sorting: a case study
JP6749961B2 (ja) 高い増殖能を有する多能性間葉系幹細胞の識別および培養のための方法
US20060223106A1 (en) Early-stage multipotential stem cells in colonies of bone marrow stromal cells
KR102490731B1 (ko) 심장의 전구체 세포의 부분모집단 단리 방법 및 의료 분야에서의 관련 용도
JP2000078968A (ja) ヒト造血幹細胞
JP6463029B2 (ja) ヒト間葉系幹細胞を特異的に認識するモノクローナル抗体並びにこれを用いたヒト間葉系幹細胞の分離及び/または品質評価を行う方法
JP2009060840A (ja) ヒト間葉系幹細胞濃縮方法
US20170226472A1 (en) Culture medium and method for enriching and maintaining cancer stem cells (cscs) using said medium
CN111534484B (zh) 一种制备cd106高表达间充质干细胞的方法、间充质干细胞及其应用和定向培养基
EP1539822B1 (de) Antikörper zur isolierung und/oder identifizierung mesenchymaler stammzellen und verfahren zur isolierung und/oder identifizierung mesenchymaler stammzellen
HK40074847A (en) Mesenchymal stem cells
EP3129469B1 (en) Cell-surface marker of early msc aging
HK40074847B (zh) 一种间充质干细胞
Torres-Barrera et al. Assessment of Cell Cycle in Primitive Chronic Myeloid Leukemia Cells by Flow Cytometry After Coculture with Endothelial Cells
US7638285B2 (en) Method of the discrimination and isolation of mammary epithelial stem and colony-forming cells
Colín FACS-Based Isolation Progenitor-Like Keratinocyte Subpopulations from HaCaT Cells for Bulk RNA-Seq Profiling
JPH10113171A (ja) 造血幹細胞様未分化細胞株

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)